Percentages of different leukocyte subpopulations expressing EGFR, EPCR, CD16, CD32, CD64, CD45RO, CD45RA, CD62L, and CD11a were able to distinguish two distinctive groups: HCs and RA patients. This evidence concerns the gene EGFR and rheumatoid arthritis.